Literature DB >> 11944954

Telomerase activity in human hepatocellular carcinoma: parallel correlation with human telomerase reverse transcriptase (hTERT) mRNA isoform expression but not with cell cycle modulators or c-Myc expression.

C-J Chen1, N-M Tsai, Y-C Liu, L I Ho, H-F Hsieh, C-Y Yen, H-J Harn.   

Abstract

BACKGROUND: To explore the possible regulatory mechanisms of telomerase, we examined the telomerase activity (TA), expression of human telomerase RNA (hTR), human telomerase reverse transcriptase (hTERT) mRNA isoforms and cell cycle modulators in human hepatocellular carcinoma (HCC) cell lines (J5, J7) and a normal human immortalized hepatic epithelial cell line (Chang-liver).
METHODS: The cell lines were chemically synchronized in either G1, G1/S, G2/M or M phases. TA was measured by polymerase chain reaction (PCR)-based telomerase repeat amplification protocol assay. The hTR and hTERT mRNA levels were analyzed by reverse transcriptase-polymerase chain reaction. Western blotting and immunocytochemistry were used to assay the cell cycle modulators.
RESULTS: The TA of J5, J7 and Chang-liver cell lines tested was highest in M phase. The expression level of hTERT mRNA associated with the highest TA detected in the M phase of HCC cell lines. Chang-liver expressed markedly less TA and hTERT mRNA than J5 or J7. The elevated TA and expression of hTERT mRNA isoforms in M phase of HCC cell lines did not significantly correlate with that of the cell cycle modulators and c-Myc.
CONCLUSIONS: The results implicate that regulation of TA is related to hTERT mRNA isoform expression, and that regulation is different between the cell immortalization and tumorigenesis. Copyright Harcourt Publishers Limited.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11944954     DOI: 10.1053/ejso.2001.1237

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  7 in total

Review 1.  Glioma: what is the role of c-Myc, hsp90 and telomerase?

Authors:  A Shervington; N Cruickshanks; H Wright; R Atkinson-Dell; R Lea; G Roberts; L Shervington
Journal:  Mol Cell Biochem       Date:  2006-02       Impact factor: 3.396

2.  Modulation of human telomerase reverse transcriptase in hepatocellular carcinoma.

Authors:  Cheng-Jueng Chen; Satoru Kyo; Yao-Chi Liu; Yeung-Leung Cheng; Chung-Bao Hsieh; De-Chuan Chan; Jyh-Cherng Yu; Horng-Jyh Harn
Journal:  World J Gastroenterol       Date:  2004-03-01       Impact factor: 5.742

Review 3.  Transcriptional Regulation of Telomerase Reverse Transcriptase (TERT) by MYC.

Authors:  Ekta Khattar; Vinay Tergaonkar
Journal:  Front Cell Dev Biol       Date:  2017-01-26

4.  The role of cellular oxidative stress in regulating glycolysis energy metabolism in hepatoma cells.

Authors:  Dong-yun Shi; Fei-zhou Xie; Chao Zhai; Jeremy S Stern; Yang Liu; Shan-lin Liu
Journal:  Mol Cancer       Date:  2009-06-05       Impact factor: 27.401

5.  A noncoding RNA gene on chromosome 10p15.3 may function upstream of hTERT.

Authors:  Norimasa Miura; Reina Sato; Tomoe Tsukamoto; Mika Shimizu; Hiroko Kabashima; Miho Takeda; Shunsaku Takahashi; Tomomi Harada; James E West; Harry Drabkin; Jose E Mejia; Goshi Shiota; Yoshikazu Murawaki; Arvind Virmani; Adi F Gazdar; Mitsuo Oshimura; Junichi Hasegawa
Journal:  BMC Mol Biol       Date:  2009-02-02       Impact factor: 2.946

Review 6.  The Molecular Mechanisms of Plant-Derived Compounds Targeting Brain Cancer.

Authors:  Hueng-Chuen Fan; Ching-Shiang Chi; Yu-Kang Chang; Min-Che Tung; Shinn-Zong Lin; Horng-Jyh Harn
Journal:  Int J Mol Sci       Date:  2018-01-30       Impact factor: 5.923

7.  TUG1 Is a Regulator of AFP and Serves as Prognostic Marker in Non-Hepatitis B Non-Hepatitis C Hepatocellular Carcinoma.

Authors:  Yang-Hsiang Lin; Meng-Han Wu; Ya-Hui Huang; Chau-Ting Yeh; Kwang-Huei Lin
Journal:  Cells       Date:  2020-01-21       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.